BioXcel Therapeutics, Inc.BTAI

Market cap

$11.39M

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	43	32	213	233	194	65	30
Total cash & short-term investments	43	32	213	233	194	65	30
Inventories	-	-	-	-	2	2	1
Total current assets	43	34	217	237	203	72	37
Property, plant and equipment, net	0	1	1	1	1	1	0
Total non-current assets	0	2	3	3	3	2	1
Total assets	44	36	220	239	206	74	38
Accounts payable	2	5	4	5	10	14	16
Total current liabilities	5	8	12	17	33	27	22
Long-term debt, non-current	-	-	-	-	93	101	103
Total non-current liabilities	-	1	1	1	96	103	109
Total liabilities	5	9	13	18	129	130	131
Common stock and paid-in capital	63	84	346	467	488	534	557
Retained earnings	-24	-57	-139	-246	-412	-591	-650
Stockholders' equity	39	27	207	222	77	-57	-93
Total debt	-	-	-	-	93	101	103
Net debt	-	-	-	-	-101	35	73
D/E ratio (%)	-	-	-	-	121.2	-178	-110.1